Abstract
Vaccination has reduced morbidity and mortality of many diseases that previously caused devastating epidemics and deaths globally. Vaccines as a biological product may contain microorganisms or their derivatives. This aspect together with the fact that they are administered to healthy individuals (mainly children) means that approximately 70% of vaccines development time is dedicated to quality control. Monoclonal antibodies (MAbs) have become essential analytical tools for application in ELISAs, Western and Dot blotting, immunoprecipitation, and flow cytometric assays that ensure the quality control of vaccines. The aim of this work is to present a review of the methods used to obtain a platform of MAbs against Neisseria meningitidis polysaccharide antigens to use as an analytical tool for quality control of anti-meningococcal polysaccharide (Ps) vaccines. The MAbs obtained are used in five sandwich ELISAs developed for Ps quantification. The assays showed good reproducibility and repeatability, with quantitation and detection limits below 1 ng/mL. Dot Blot, as the Identity test of the Ps vaccine, was carried out to positively identify licensed and experimental vaccines. All assays described are suitable for the screening of multiple vaccine samples and could be useful for monitoring lot-to-lot consistency and stability.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Greenwood B (2014) The contribution of vaccination to global health: past, present and future. Philos Trans R Soc Lond Ser B Biol Sci 369(1645):20130433
Bustreo F, Okwo-Bele JM, Kamara L (2015) World Health Organization perspectives on the contribution of the global alliance for vaccines and immunization on reducing child mortality. Arch Dis Child 100(Suppl 1):s34–s37
WHO. Web page: http://www.who.int/immunization/documents/positionpapers/en/. Immunization, vaccines and biologicals
US Pharmacopeia (2007) Guideline for Submitting Requests for Revision to USP-NF. V3.1 April.VACCINES
WHO. Web page http://www.who.int/immunization/quality_safety/en/. Vaccine and immunization quality and safety
CECMED (2000) Requisitos para la liberación de lotes de vacunas. Regulación No.19-2000. CECMED, La Habana
European Pharmacopoeia 5.0. 01/2005:20701. 2.7.1. Immunochemical methods. p 1879
Ochoa RF (2013) Técnicas inmunoenzimáticas en el desarrollo clínico de vacunas, Primera Edición. Finlay Ediciones, Havana, Cuba
Saydam M, Rigsby P, Mawas F (2014) A novel enzyme-linked immuno-sorbent assay (ELISA) for the quantification of total and free polysaccharide in Haemophilus influenzae B Tetanus toxoid conjugate vaccines in monovalent and combined vaccine formulations. Biologicals 42:29–33
Saleem M, Kamal M (2008) Monoclonal antibodies in clinical diagnosis: a brief review application. Afr J Biotechnol 7:923–925
Payne WJ, Marshall DL, Shockley RK, Martin WJ (1988) Clinical laboratory applications of monoclonal antibodies. Clin Microbiol Rev 1:313–329
Falero G, Rodríguez BL, Rodríguez I, Campos J, Ledon T, Valle E, Silva Y, Marrero K, Suzarte E, Valmaseda T, Moreno A, Fando R (2003) Production and characterization of monoclonal antibodies to E1 Tor toxin co-regulated pilus of Vibrio cholerae. Hybrid Hybridomics 22(5):315–320
Barberá R, Domínguez F, Otero O, Gutiérrez M, Falero G, Reyes G, Sotolongo F, Sierra G (2011) Development and characterization of murine monoclonal antibody specific for the P1.4 PorA proteins from strain B: 4:P1.(7b).4. of Neisseria meningitidis. Vaccimonitor 20:6–10
Waliza A, Shyamasree G (2013) Monoclonal antibodies: a tool in clinical research. Indian J Clin Med 4:9–21
Hnasko RM, Stanker LH (2015) Hybridoma technology. In: ELISA: methods and protocols, Methods in molecular biology, vol 1318. Springer Science+Business Media, New York
Ward PA et al (1999) Monoclonal antibody production. A report of the committee on methods of producing monoclonal antibodies. Institute for laboratory animal research. National Research Council
Reyes F, Amin N, Otero O, Aguilar A, Cuello M, Valdés Y, García LG, Cardoso D, Camacho F (2013) Four monoclonal antibodies against capsular polysaccharides of Neisseria meningitidis serogroups A, C, Y and W135: its application in identity tests. Biologicals 41(4):275–278
Yokoyama WM (2001) Monoclonal antibody supernatant and ascites fluid production. Curr Protoc Immunol 40:2.6.1–2.6.9
Fitzgerald J, Leonard P, Darcy E, O’Kennedy R (2011) Immunoaffinity chromatography. Methods Mol Biol 681:35–59
ImmunoReagents Inc. (2015) Antibody purification methods. IRU - ImmunoReagents University, Raleigh, NC
Ezzatifar F, Majidi J, Baradaran B, Maleki LA, Abdolalizadeh J, Yousefi M (2015) Large scale generation and characterization of anti-human IgA monoclonal antibody in ascitic fluid of Balb/c mice. Adv Pharm Bull 5(1):97–102
Amersham Pharmacia Biotech (2001) Affinity chromatography. Principles and methods. Handbooks. Editon AC 18-1022-29. Amersham Pharmacia Biotech, Little Chalfont
Beatty JD, Beatty BG, Vlahos WG (1987) Measurement of monoclonal antibody affinity by non-competitive enzyme immunoassay. J Immunol Methods 100:173–179
Johnson M (2013) Mouse antibody isotypes/classes and subclasses. Mater methods 3:152 (Labome. http://www.labome.com/method/Mouse-Antibody.html)
Clark M Antibody-antigen reactions. Department of pathology. University of Cambridge, Cambridge
Frank SA (2002) Specificity and cross-reactivity. In: Immunology and evolution of infectious disease. Princeton University Press, Princeton, NJ
Agnememel A, Traincard F, Dartevelle S, Mulard L, Mahamane AE, Oukem-Boyer OO, Denizon M, Kacou-N Douba A, Dosso M, Gake B, Lombart JP, Taha MK (2015) Development and evaluation of a dipstick diagnostic test for Neisseria meningitidis serogroup X. Clin Microbiol 53:449–454
Wedege E, Høiby EA, Rosenqvist E, Frøholm LO (1990) Serotyping and subtyping of Neisseria meningitidis isolates by co-agglutination, dot-blotting and ELISA. J Med Microbiol 31:195–201
Ortika BD, Habib M, Dunne EM, Porter BD, Satzke C (2013) Production of latex agglutination reagents for pneumococcal serotyping. BMC Res Notes 6:49
Cook MC, Gibeault S, Filippenko V, Ye Q, Wang J, Kunkel JP (2013) Serogroup quantitation of multivalent polysaccharide and polysaccharide conjugate meningococcal vaccines from China. Biologicals 41:261–268
Cook MC, Bliu A, Kunkel JP (2013) Quantitation of serogroups in multivalent polysaccharide-based meningococcal vaccines: optimisation of hydrolysis conditions and chromatographic methods. Vaccine 31:3702–3711
Reyes F, Otero O, Cuello M, Amin N, García L, Cardoso D, Camacho F (2014) Development of four sandwich ELISAs for quantitation of capsular polysaccharides from Neisseria meningitidis serogroups A, C, W and Y in multivalent vaccines. J Immunol Methods 407:58–62
Chen PS, Toribara TY, Warner H (1956) Microdetermination of phosphorus. Anal Chem 28:1756–1758
Svennerholm L (1957) Quantitative estimation of sialic acids. II. A colorimetric resorcinol-hydrochloric acid method. Biochim Biophys Acta 24:604–611
Lamb DH, Lei QP, Hakim N, Rizzo S, Cash P (2005) Determination of meningococcal polysaccharides by capillary zone electrophoresis. Anal Biochem 338:263–269
Kao G, Tsai CM (2004) Quantification of O-acetyl, N-acetyl and phosphate groups and determination of the extent of O-acetylation in bacterial vaccine polysaccharides by high-performance anion-exchange chromatography with conductivity detection (HPAEC-CD). Vaccine 22:335–344
Crowther JR (2009) The ELISA guidebook, Methods in molecular biology, vol 516. Humana Press, New York
Plikaytis BD, Carlone GM, Edmonds P, Mayer LW (1986) Robust estimation of standard curves for protein molecular weight and linear-duplex DNA base-pair number after gel electrophoresis. Anal Biochem 152:346–364
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
González, E. et al. (2019). Monoclonal Antibodies Against the Capsular Polysaccharides A, C, Y, W, and X of Neisseria meningitidis: A Platform for the Quality Control of Meningococcal Vaccines. In: Seib, K., Peak, I. (eds) Neisseria meningitidis. Methods in Molecular Biology, vol 1969. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-9202-7_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9202-7_13
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-9201-0
Online ISBN: 978-1-4939-9202-7
eBook Packages: Springer Protocols